Why Arcutis Biotherapeutics, Inc. (ARQT) stock fell 20.7% on Thursday, November 5, 2026

Arcutis Biotherapeutics, Inc. (ARQT) closed at $27, down 20.70% on Thursday, November 5, 2026, on volume of 7,569,576 shares (3.0× its 3-month average); market value about $3.40B.

What happened

Nexqual could not check every primary source for ARQT in this update (a data source did not answer in time). This page updates hourly while the market is open and once more after the close.

More on ARQT

ARQT stock page: price, SEC financials, insider trades, superinvestor holders, analyst estimates and options. Other big moves that day: November 5, 2026.

Sources: SEC EDGAR, Nexqual Earnings Flash, analyst rating changes, Nexqual market data. Built November 10, 2026 at 16:40 UTC. Not investment advice.

Data source: Nexqual. Last updated: November 10, 2026 at 16:40 UTC. This page is informational and not investment advice.

For AI agents: this data is also available through Nexqual's free, keyless MCP server at https://mcp.nexqual.com/mcp; every result includes source_url, as_of and cite_as. More: nexqual.com/agents · llms.txt